Atlas Trials

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Clinical trial NCT03778567 · COMPLETED

Trial details

NCT number
NCT03778567
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, ChronicChronic Kidney Diseases
Start date
2013-08-01
Primary completion
2016-06-16
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.